Package 21130-639-71

Brand: naproxen sodium pm

Generic: diphenhydramine hydrochloride, naproxen sodium
NDC Package

Package Facts

Identity

Package NDC 21130-639-71
Digits Only 2113063971
Product NDC 21130-639
Product ID 21130-639_f966deeb-c8cb-484a-96f7-678e755bc8ab
Description

1 BOTTLE in 1 CARTON (21130-639-71) / 50 TABLET, FILM COATED in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2025-03-13
Brand naproxen sodium pm
Generic diphenhydramine hydrochloride, naproxen sodium
Sample Package No

Linked Drug Pages (1)

NAPROXEN SODIUM PM ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f966deeb-c8cb-484a-96f7-678e755bc8ab", "openfda": {"upc": ["0321130187172"], "unii": ["TC2D6JAD40", "9TN87S3A3C"], "rxcui": ["1550957"], "spl_set_id": ["60cb7b6e-f2d2-48ca-8db7-7124717735d5"], "manufacturer_name": ["Safeway"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (21130-639-71)  / 50 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "21130-639-71", "marketing_start_date": "20250313"}], "brand_name": "NAPROXEN SODIUM PM", "product_id": "21130-639_f966deeb-c8cb-484a-96f7-678e755bc8ab", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "21130-639", "generic_name": "diphenhydramine hydrochloride, naproxen sodium", "labeler_name": "Safeway", "product_type": "HUMAN OTC DRUG", "brand_name_base": "NAPROXEN SODIUM PM", "active_ingredients": [{"name": "DIPHENHYDRAMINE HYDROCHLORIDE", "strength": "25 mg/1"}, {"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA208499", "marketing_category": "ANDA", "marketing_start_date": "20250313", "listing_expiration_date": "20261231"}